《柳葉刀》市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、最終用戶、地區和競爭細分，2019-2029 年

2023 年，全球柳葉刀市場估值為23.9 億美元，到2029 年，預測期內將以9.83% 的複合年成長率實現令人印象深刻的成長。血液樣本以進行診斷測試或監測的醫療設備目的。它們通常用於醫療機構、實驗室以及個人自我監測血糖水平和其他健康參數。刺血針通常用於糖尿病患者的血糖監測，其中頻繁監測血糖水平對於糖尿病管理至關重要。它們也用於臨床環境中的診斷測試、篩檢計劃和監測各種健康參數，如膽固醇水平、血紅蛋白水平和傳染病。柳葉刀主體是一種小型手持設備，可固定針頭並促進安全和受控的皮膚穿刺。它可能具有人體工學設計和安全機制，以提高使用者舒適度並最大限度地減少意外針刺傷害的風險。許多刺血針都採用安全機制，例如可伸縮針頭、保護帽或防護罩，以防止針刺傷並最大限度地減少交叉污染的風險。這些安全功能在使用後會自動激活，或透過簡單的觸發機制來保護針頭並減少與血源性病原體的接觸。

市場概況
預測期	2025-2029
2023 年市場規模	23.9億美元
2029 年市場規模	42億美元
2024-2029 年複合年成長率	9.83%
成長最快的細分市場	安全採血針
最大的市場	北美洲

隨著全球人口老化，慢性疾病和病症的盛行率越來越高，需要定期監測。採血針對糖尿病患者的血糖監測和老年人的各種診斷測試至關重要。技術進步：刺血針設計和技術的不斷創新帶來更安全、更有效率和更方便用戶使用的刺血針。可伸縮針頭、可調節刺入深度和自動採血裝置等先進技術提高了患者的舒適度和依從性，推動了市場成長。人們越來越認知到早期發現和管理慢性病的重要性，這促進了對柳葉刀的需求。醫療保健組織和公共衛生計劃推動糖尿病和心血管疾病等疾病的篩檢計劃，進一步推動了市場成長。向分散式醫療保健和即時檢測的轉變推動了對刺血針的需求，因為它們是在傳統實驗室環境之外進行快速診斷測試的血液採集的組成部分。

主要市場促進因素

技術進步

提高認知和篩檢計劃

對即時檢測 (POCT) 的需求不斷成長

主要市場挑戰

針刺傷和安全問題

競爭和定價壓力

主要市場趨勢

家庭醫療保健

細分市場洞察

類型洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球柳葉刀市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依類型（安全採血針、標準採血針、特殊採血針）
  • 依應用（血糖測試、血紅素測試、凝血測試、其他應用）
  • 按最終使用者（醫院和診所、家庭護理機構、其他）
  • 按地區
  • 按公司分類 (2023)
• 市場地圖

第 6 章：北美柳葉刀市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按類型
  • 按申請
  • 按最終用戶
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第 7 章：歐洲柳葉刀市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按類型
  • 按申請
  • 按最終用戶
  • 按國家/地區
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第 8 章：亞太地區柳葉刀市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按類型
  • 按申請
  • 按最終用戶
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 9 章：南美柳葉刀市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按類型
  • 按申請
  • 按最終用戶
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲《柳葉刀》市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按類型
  • 按申請
  • 按最終用戶
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 促進要素
• 挑戰

第 12 章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最近的發展

第 13 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第14章：競爭格局

• F. Hoffmann-La Roche Ltd
• Ypsomed AG
• B. Braun SE
• Terumo Medical Corporation
• Owen Mumford Ltd
• HTL-STREFA SA (MTD Medical Technology and Devices SpA)
• ARKRAY, Inc
• Sarstedt AG & Co. KG
• Medline Industries, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

Global Lancets Market was valued at USD 2.39 billion in 2023 and will see an impressive growth in the forecast period at a CAGR of 9.83% through 2029. Lancets are medical devices used for puncturing the skin to obtain a small blood sample for diagnostic testing or monitoring purposes. They are commonly used in healthcare settings, laboratories, and by individuals for self-monitoring of blood glucose levels and other health parameters. Lancets are commonly used for blood glucose monitoring in individuals with diabetes, where frequent monitoring of blood glucose levels is essential for diabetes management. They are also used in clinical settings for diagnostic testing, screening programs, and monitoring of various health parameters such as cholesterol levels, hemoglobin levels, and infectious diseases. The lancet body is a small, handheld device that holds the needle and facilitates safe and controlled skin puncture. It may feature ergonomic designs and safety mechanisms to enhance user comfort and minimize the risk of accidental needlestick injuries. Many lancets incorporate safety mechanisms such as retractable needles, protective caps, or shields to prevent needlestick injuries and minimize the risk of cross-contamination. These safety features activate automatically after use or with a simple trigger mechanism to shield the needle and reduce exposure to bloodborne pathogens.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 2.39 Billion
Market Size 2029	USD 4.20 Billion
CAGR 2024-2029	9.83%
Fastest Growing Segment	Safety Lancets
Largest Market	North America

As the global population ages, there is a higher prevalence of chronic diseases and conditions that require regular monitoring. Lancets are crucial for blood glucose monitoring in diabetic patients and for various diagnostic tests in the elderly population. Technological Advancements: Continuous innovations in lancet design and technology lead to safer, more efficient, and user-friendly lancets. Advancements such as retractable needles, adjustable penetration depths, and automatic lancing devices improve patient comfort and compliance, driving market growth. Growing awareness about the importance of early detection and management of chronic diseases contributes to the demand for lancets. Healthcare organizations and public health initiatives promoting screening programs for conditions like diabetes and cardiovascular diseases further fuel market growth. The shift towards decentralized healthcare and point-of-care testing drives the demand for lancets, as they are integral components of blood collection for rapid diagnostic tests performed outside traditional laboratory settings.

Key Market Drivers

Technological Advancements

Lancets with retractable needles feature mechanisms that retract the needle into the lancet body after use, reducing the risk of accidental needlestick injuries and preventing cross-contamination. Advanced lancets allow users to adjust the penetration depth of the needle based on individual skin thickness and sensitivity. This customization improves user comfort and ensures optimal blood sample collection. Automatic lancing devices automate the blood sampling process by spring-loading the lancet and activating it with the push of a button or a trigger mechanism. These devices provide consistent and precise lancing, minimizing user variability and discomfort.

Alternate Site Testing (AST) Lancets are designed for blood sampling from alternate sites such as the forearm, palm, or thigh, offering greater flexibility and convenience for patients who prefer to avoid fingerstick testing. Pre-loaded lancets come with pre-installed needles, eliminating the need for manual loading and reducing the risk of needlestick injuries during lancet assembly. This feature enhances user safety and simplifies the blood sampling process. Some lancets feature visual indicators or indicators that audibly click upon activation, providing feedback to users to confirm proper lancing and ensure accurate blood sample collection.

Micro-needle lancets employ ultra-fine needles designed to minimize pain and discomfort during blood sampling. These lancets penetrate the skin with minimal force, reducing tissue trauma and enhancing patient comfort. Lancets with integrated safety mechanisms incorporate features such as needle shields, caps, or locking mechanisms to prevent accidental needlestick injuries and protect users from exposure to contaminated needles. Some lancets are equipped with Bluetooth technology, allowing for wireless connectivity with mobile devices or glucometers. Bluetooth-enabled lancets facilitate seamless data transfer, enabling real-time monitoring and analysis of blood glucose levels. Lancets made from biodegradable materials or environmentally friendly alternatives help reduce environmental impact and promote sustainability in healthcare practices. This factor will help in the development of the Global Lancets Market.

Increasing Awareness and Screening Programs

Diabetes awareness campaigns educate people about the importance of regular blood glucose monitoring, which requires the use of lancets. These campaigns promote early detection, management, and prevention of diabetes-related complications, thereby increasing the demand for lancets. Screening programs for cardiovascular diseases often involve blood tests to assess lipid levels, clotting factors, and other cardiovascular risk markers. Lancets are essential for collecting blood samples during these screenings, contributing to increased demand for lancets. Governments, healthcare organizations, and non-profit agencies promote preventive healthcare initiatives that emphasize regular health screenings and check-ups. Lancets are necessary for blood collection during various screening tests, including cholesterol screenings, hemoglobin tests, and HIV screenings.

Screening programs for women's health issues such as cervical cancer, breast cancer, and sexually transmitted infections (STIs) often involve blood tests. Lancets are used to collect blood samples for STI testing and other health assessments related to women's health, contributing to the demand for lancets. Public health campaigns targeting specific health issues, such as bloodborne infections, anemia, and genetic disorders, raise awareness about the importance of regular blood testing and screening. Lancets play a crucial role in facilitating blood sample collection for diagnostic purposes, driving demand.

Community health fairs and outreach programs often include free or low-cost health screenings for various conditions, including diabetes, hypertension, and infectious diseases. Lancets are needed for on-site blood sampling, making them integral to these community health initiatives and increasing their demand. Health education programs conducted by healthcare providers, schools, workplaces, and community organizations educate individuals about the importance of monitoring their health and seeking preventive care. Lancets are essential tools for blood glucose monitoring, anemia testing, and other health assessments promoted through these education programs. This factor will pace up the demand of the Global Lancets Market.

Rising Demand for Point-of-Care Testing (POCT)

Point-of-care testing (POCT) allows for rapid diagnostic testing outside of traditional laboratory settings, providing immediate results to patients and healthcare providers. Lancets are essential for collecting blood samples for POCT, enabling quick and convenient on-site testing without the need for laboratory facilities. POCT reduces the turnaround time for diagnostic testing, allowing for timely clinical decision-making and patient management. Lancets facilitate rapid blood sample collection, enabling healthcare providers to perform tests such as blood glucose monitoring, cholesterol screening, and infectious disease testing at the point of care. POCT enables healthcare providers to make immediate treatment decisions based on real-time test results, leading to improved patient outcomes and satisfaction. Lancets play a critical role in facilitating timely blood sample collection for POCT, contributing to better patient care and management of acute and chronic conditions. POCT facilitates the monitoring of chronic conditions such as diabetes, cardiovascular diseases, and infectious diseases through regular testing of biomarkers and health parameters. Lancets enable patients and healthcare providers to perform frequent blood tests for disease monitoring and management, promoting early intervention and treatment adjustments as needed.

The decentralization of healthcare services and the shift towards community-based care models increase the demand for POCT and related devices such as lancets. POCT allows for healthcare services to be delivered closer to patients' homes, workplaces, and community settings, improving access to diagnostic testing and promoting early detection of health conditions. POCT is particularly valuable in emergency and urgent care settings where rapid diagnosis and treatment are critical. Lancets enable healthcare providers to quickly collect blood samples for immediate testing, helping to triage patients, guide treatment decisions, and optimize resource utilization in emergency situations. POCT and lancets are invaluable in remote and resource-limited settings where access to laboratory facilities may be limited or unavailable. Lancets allow healthcare providers to perform diagnostic testing in challenging environments such as rural areas, disaster relief operations, and developing countries, improving healthcare access and outcomes for underserved populations. This factor will accelerate the demand of the Global Lancets Market.

Key Market Challenges

Needlestick Injuries and Safety Concerns

Needlestick injuries pose a significant occupational hazard for healthcare workers who handle lancets and other sharp medical devices. These injuries can result in exposure to bloodborne pathogens, such as HIV, hepatitis B, and hepatitis C, leading to potential infections and health risks for healthcare professionals. Safety concerns also extend to patients who use lancets for self-monitoring of blood glucose levels and other medical purposes. Improper handling or disposal of lancets can increase the risk of needlestick injuries and cross-contamination, posing safety risks to patients, caregivers, and family members. Regulatory agencies impose stringent guidelines and standards for the design, manufacturing, and usage of lancets to minimize the risk of needlestick injuries and ensure user safety. Compliance with regulatory requirements can be challenging for lancet manufacturers and healthcare facilities, necessitating investments in safety features and training programs. Needlestick injuries can lead to the transmission of infectious diseases from contaminated lancets or blood samples. Preventing needlestick injuries is essential for reducing the risk of infection transmission and maintaining a safe healthcare environment for patients and healthcare workers. Needlestick injuries can result in significant healthcare costs, including medical treatment, testing, and potential long-term consequences for affected individuals. Healthcare facilities may incur additional expenses related to employee compensation, insurance claims, and productivity losses associated with needlestick injuries.

Competition and Pricing Pressure

The lancets market is highly competitive, with numerous manufacturers offering a wide range of products. The saturation of the market intensifies competition among manufacturers, leading to pricing pressures as companies strive to gain market share and maintain profitability. Intense competition often results in price wars among lancet manufacturers. Companies may lower prices to attract customers, leading to downward pressure on profit margins and overall pricing levels within the market. Many lancet products offer similar functionalities and features, making it challenging for manufacturers to differentiate their offerings and justify premium pricing. This lack of product differentiation exacerbates pricing pressures and intensifies competition in the market. The entry of generic or private-label lancet brands further intensifies competition and pricing pressures in the market. Generic brands often offer comparable quality at lower prices, enticing price-conscious consumers and eroding market share for established brands. Healthcare providers, including hospitals, clinics, and laboratories, often negotiate pricing contracts with lancet manufacturers to secure favorable pricing terms. The bargaining power of healthcare providers can exert additional pressure on manufacturers to lower prices and offer discounts to remain competitive in the market. Lancet manufacturers may implement cost reduction strategies to mitigate pricing pressures and maintain profitability. These strategies may include streamlining manufacturing processes, optimizing supply chain management, and outsourcing production to lower-cost regions.

Key Market Trends

Home Healthcare

With the increasing prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases, there is a growing need for regular monitoring of health parameters, including blood glucose levels. Lancets play a crucial role in home healthcare by enabling patients to perform self-monitoring of blood glucose levels conveniently and effectively. There is a growing emphasis on patient-centered care and empowerment, where patients take an active role in managing their health conditions. Lancets empower patients to monitor their health from the comfort of their homes, promoting self-management and adherence to treatment plans. Home healthcare offers patients the convenience of monitoring their health without the need for frequent visits to healthcare facilities. Lancets designed for home use are user-friendly, portable, and often feature pain-reducing technologies, enhancing patient comfort and compliance with blood sampling procedures. Technological advancements have led to the development of innovative lancets and blood glucose monitoring devices that are specifically designed for home use. These devices may feature wireless connectivity, data storage, and analysis capabilities, enabling patients to track their health data and share it with healthcare providers remotely. The COVID-19 pandemic has accelerated the adoption of home healthcare solutions, as patients seek to minimize exposure to healthcare settings and reduce the risk of infection transmission. Lancets enable patients to perform blood sampling and monitoring at home, reducing the need for in-person clinic visits and promoting social distancing measures.

Segmental Insights

Type Insights

The Safety Lancets segment is projected to experience rapid growth in the Global Lancets Market during the forecast period. Safety lancets are designed with built-in safety mechanisms to minimize the risk of needlestick injuries among healthcare professionals and patients. With an increasing focus on workplace safety and infection control, there is a growing demand for safety lancets across healthcare settings. Regulatory agencies and healthcare organizations have implemented stringent guidelines and mandates aimed at reducing needlestick injuries and promoting safe blood collection practices. Compliance with these regulations often requires the use of safety lancets, driving market growth. Needlestick injuries pose a significant occupational hazard for healthcare workers, exposing them to the risk of bloodborne infections and injuries. Safety lancets offer an effective solution for mitigating this risk, leading to their widespread adoption in hospitals, clinics, and other healthcare settings. Safety lancets are designed to be user-friendly and less intimidating for patients, particularly those who require frequent blood sampling. The ease of use and reduced discomfort associated with safety lancets can improve patient compliance with blood collection procedures, driving market growth. The prevalence of chronic diseases such as diabetes and hypertension is increasing worldwide, necessitating regular blood monitoring and testing. Safety lancets are an essential tool for collecting blood samples for diagnostic purposes, contributing to their growing demand in the healthcare industry. Increasing healthcare expenditure and investments in healthcare infrastructure, particularly in emerging markets, are fueling the adoption of safety lancets. Healthcare facilities are prioritizing the purchase of safety lancets to ensure compliance with safety standards and protect the well-being of their staff and patients.

Regional Insights

North America emerged as the dominant region in the Global Lancets Market in 2023. North America has a relatively high prevalence of chronic diseases such as diabetes. Lancets are essential for blood glucose monitoring, which is a routine part of managing diabetes. The large diabetic population in North America drives the demand for lancets and related products. North America boasts advanced healthcare infrastructure and facilities, which support the diagnosis, treatment, and management of various medical conditions, including diabetes and other diseases that require blood testing. The availability of healthcare services and products, including lancets, contributes to the dominance of North America in the lancets market. The region has been at the forefront of technological advancements in healthcare, including the development of innovative lancets with improved safety features and ease of use. Technological innovation drives market growth and enhances the adoption of lancets among healthcare professionals and patients.

Key Market Players

F. Hoffmann-La Roche Ltd

Ypsomed AG

B. Braun SE

Terumo Medical Corporation

Owen Mumford Ltd

HTL-STREFA S.A. (MTD Medical Technology and Devices S.p.A.)

ARKRAY, Inc

Sarstedt AG & Co. KG

Medline Industries, Inc.

Report Scope:

In this report, the Global Lancets Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lancets Market, By Type:

Safety Lancets Standard Lancets Specialty Lancets

Lancets Market, By Application:

Glucose Testing Haemoglobin Testing Coagulation Testing Other Applications

Lancets Market, By End User:

Hospitals and Clinics Home Care Settings Others

Lancets Market, By Region:

North America

United States

Canada

Mexico

Europe

Germany

United Kingdom

France

Italy

Spain

Asia-Pacific

China

Japan

India

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lancets Market.

Available Customizations:

Global Lancets Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lancets Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Safety Lancets, Standard Lancets, Specialty Lancets)
  • 5.2.2. By Application (Glucose Testing, Haemoglobin Testing, Coagulation Testing, Other Applications)
  • 5.2.3. By End User (Hospitals and Clinics, Home Care Settings, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2023)
• 5.3. Market Map

6. North America Lancets Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Lancets Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Lancets Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Lancets Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Lancets Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Lancets Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Lancets Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Lancets Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Lancets Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Lancets Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Lancets Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Lancets Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Lancets Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Lancets Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Lancets Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Lancets Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Lancets Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Lancets Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Lancets Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Lancets Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Lancets Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Lancets Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Lancets Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Lancets Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. F. Hoffmann-La Roche Ltd
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Ypsomed AG
• 14.3. B. Braun SE
• 14.4. Terumo Medical Corporation
• 14.5. Owen Mumford Ltd
• 14.6. HTL-STREFA S.A. (MTD Medical Technology and Devices S.p.A.)
• 14.7. ARKRAY, Inc
• 14.8. Sarstedt AG & Co. KG
• 14.9.Medline Industries, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer